Advanced company searchLink opens in new window

CATALENT PHARMA SOLUTIONS LIMITED

Company number 03761135

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Mar 2024 CS01 Confirmation statement made on 21 March 2024 with no updates
20 Mar 2024 CS01 Confirmation statement made on 20 March 2024 with updates
07 Dec 2023 CH01 Director's details changed for Mr Ricky Wayne Hobson on 7 December 2023
07 Dec 2023 AP01 Appointment of Mr Ricky Wayne Hobson as a director on 4 December 2023
03 Nov 2023 AP01 Appointment of Mr. Ramon Javier Ceron as a director on 2 October 2023
01 Nov 2023 TM01 Termination of appointment of Jonathan Arnold as a director on 29 September 2023
01 Nov 2023 TM01 Termination of appointment of Steven Fasman as a director on 13 September 2023
23 Aug 2023 AP01 Appointment of Mr Steven Fasman as a director on 16 August 2023
06 Jun 2023 AA Full accounts made up to 30 June 2022
03 May 2023 TM01 Termination of appointment of Thomas Castellano as a director on 21 April 2023
31 Mar 2023 CS01 Confirmation statement made on 31 March 2023 with updates
31 Mar 2023 CS01 Confirmation statement made on 20 March 2023 with updates
29 Jun 2022 SH01 Statement of capital following an allotment of shares on 29 June 2022
  • GBP 41,933,689.75
22 Jun 2022 AP01 Appointment of Mr Thomas Castellano as a director on 31 May 2022
21 Jun 2022 TM01 Termination of appointment of Alessandro Maselli as a director on 31 May 2022
07 Apr 2022 AA Full accounts made up to 30 June 2021
24 Mar 2022 CS01 Confirmation statement made on 20 March 2022 with no updates
18 Nov 2021 TM02 Termination of appointment of Alex Reed as a secretary on 22 October 2021
30 Apr 2021 CS01 Confirmation statement made on 20 March 2021 with no updates
19 Dec 2020 AA Full accounts made up to 30 June 2020
09 Jul 2020 AA Full accounts made up to 30 June 2019
03 Apr 2020 CS01 Confirmation statement made on 20 March 2020 with no updates
23 Sep 2019 PSC02 Notification of Catalent, Inc. as a person with significant control on 6 April 2016
19 Sep 2019 PSC09 Withdrawal of a person with significant control statement on 19 September 2019
11 Sep 2019 TM02 Termination of appointment of Kirk Walsh as a secretary on 30 August 2019